Literature DB >> 7453783

Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.

D E Chenoweth, S W Cooper, T E Hugli, R W Stewart, E H Blackstone, J W Kirklin.   

Abstract

We observed complement activation in 15 adults undergoing total cardiopulmonary bypass. Plasma levels of C3a were significantly elevated (P < 0.0001) at the beginning of the procedure, and they continued to increase steadily thereafter. At the end of the procedure, C3a levels were more than five times higher than preoperative levels. Plasma levels of C5a (a factor that binds avidly to neutrophils) did not change significantly during cardiopulmonary bypass. Instead, there was significant neutrophilia (P = 0.03) during bypass, and significant transpulmonary neutropenia (P = 0.0002) occurred when cardiopulmonary circulation was reestablished at partial bypass. The neutropenia is consistent with pulmonary-vascular sequestration of C5a-activated granulocytes. We also found that incubation of blood with the nylon-mesh liner of bubble oxygenators, as well as vigorous oxygenation of whole blood, promotes conversion of complement. We conclude that the complement-derived inflammatory mediators C3a and C5a produced during extracorporeal circulation may contribute to the pathogenesis of "post-pump syndromes."

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7453783     DOI: 10.1056/NEJM198102263040901

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  112 in total

1.  Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery.

Authors:  Joseph Deptula; Kimberly Glogowski; Kellie Merrigan; Kim Hanson; Donald Felix; James Hammel; Kim Duncan
Journal:  J Extra Corpor Technol       Date:  2006-03

2.  Complement activation during cardiac and thoracic vascular operations.

Authors:  P G Loubser
Journal:  Tex Heart Inst J       Date:  1987-12

3.  The effect of temperature and shear rate on platelet aggregation.

Authors:  A P Shortland; N P Rhodes; A Rattray; R A Black; D F Williams
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

4.  In vitro complement activation after contact with pyrolytic carbon-coated and uncoated polyethylene terephthalate.

Authors:  E Cenni; D Granchi; G Ciapetti; S Stea; E Verri; S Gamberini; A Gori; A Pizzoferrato; P Zucchelli
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

Review 5.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

Authors:  M Peakman; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

Review 6.  Attenuating the Systemic Inflammatory Response to Adult Cardiopulmonary Bypass: A Critical Review of the Evidence Base.

Authors:  R Clive Landis; Jeremiah R Brown; David Fitzgerald; Donald S Likosky; Linda Shore-Lesserson; Robert A Baker; John W Hammon
Journal:  J Extra Corpor Technol       Date:  2014-09

7.  Complement conversion and leukocyte kinetics in open heart surgery.

Authors:  J Utoh; T Yamamoto; T Kambara; H Goto; Y Miyauchi
Journal:  Jpn J Surg       Date:  1988-05

8.  IL-6 and TNF alpha release in association with neutrophil activation after cardiopulmonary bypass surgery.

Authors:  R G Holzheimer; R G Molloy; H Görlach; S Wilkert; F Hehrlein
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

9.  Oxygen consumption after cardiopulmonary bypass--implications of different measuring methods.

Authors:  H M Oudemans-van Straaten; G J Scheffer; L Eysman; C R Wildevuur
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

10.  C3aR inhibition reduces neurodegeneration in experimental lupus.

Authors:  A Jacob; L Bao; J Brorson; R J Quigg; J J Alexander
Journal:  Lupus       Date:  2009-11-09       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.